H 34552

Drug Profile

H 34552

Alternative Names: H 345

Latest Information Update: 07 Feb 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator AstraZeneca
  • Class Class III antiarrhythmics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arrhythmias

Most Recent Events

  • 07 Feb 2003 Discontinued - Phase-II for Arrhythmias in Sweden (unspecified route)
  • 10 May 2000 A preclinical study has been added to the pharmacodynamics section
  • 28 Mar 2000 Phase-II clinical trials for Arrhythmias in Sweden (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top